Chief People Officer Sally Massey sold ~8,600 shares for $751,633, her 9th open-market sale in 36 months.
Sally Massey, Colgate's Chief People Officer, sold a significant portion of her holdings—nearly two-fifths of her stake—in a sale that continues a consistent pattern of open-market dispositions. Over the past three years, she has executed nine open-market sales with no offsetting purchases, positioning her as a net seller. Her prior sales at this ticker have produced mixed timing results: some occurred just before the stock declined, while others preceded gains, suggesting she has not consistently exited at optimal moments. The stock currently trades below its 52-week high and has declined modestly over the past quarter, creating a less favorable backdrop for interpreting this sale as opportunistic. Colgate remains a profitable company with steady revenue growth and a substantial market value, so this sale does not suggest financial distress at the company level; rather, it reflects the insider's personal portfolio decisions independent of company fundamentals.
Colgate CHRO sells 15.9K shares at $95.03; holdings cut 53.5% to 13.8K shares.
Sally Massey, Chief Human Resources Officer at Colgate Palmolive, sold 15,851 shares on 2026-02-05 at $95.03, reducing her holdings by 53.5% from 29,602 to 13,751 shares and raising $1,506,287.24. The sale occurred at a price near the 52-week high of $97.50 (-3.4% from peak) and follows a 30-day rally of +15.6% and 90-day gain of +18.5%, suggesting the stock was trading near elevated recent levels at the time of disposal. Looking at her same-ticker history at CL, she has sold five times previously; only two of those five prior sells showed negative 90-day returns (well-timed), while the most recent sell at CL on 2025-02-25 followed by a +0.6% 90-day gain was poorly timed. Her cross-ticker track record across all holdings shows an average 90-day return of -0.1% after sells with a 50% well-timed rate, providing limited directional conviction from her broader pattern. This large reduction in CL holdings at elevated valuations warrants observation of whether near-term price momentum sustains or reverses.
CHRO Sally Massey sells 8.0K shares of CL at $92.02; stock down -6.6% in 90 days post-announcement.
Sally Massey, Chief Human Resources Officer, sold 8,000 shares (35.1% of her then-holdings) on 2025-02-25 at $92.02 per share for $736,152.00. The current price of $90.20 is -17.1% from the 52-week high of $108.77, indicating a period of weakness. Massey's prior sales at CL have shown mixed timing: 3 of her 5 prior sells at this ticker exhibited negative 90-day returns (well-timed), though 2 were followed by positive returns. Her cross-ticker track record shows 60.00% well-timed sells with an average 90-day return of -0.3% across all tickers, suggesting modest predictive value. The sale itself is material—reducing her CL holdings from 22,805 to 14,805 shares—but falls within routine CHRO-level portfolio activity at a mid-cap consumer-staples holding (market cap $73.2B, P/E 21.17, recent revenue growth +3.3%).
Massey Sally, Chief Human Resources Officer, sold 15,850 shares at $103.28 on 2024-08-06, reducing her post-transaction holding to 13,942 shares (a -53.2% reduction). The sale occurred near the 52-week high of $102.81, and at a price $0.57 above the current price of $102.71. Her cross-ticker track record across 4 prior sells shows an average 90-day return of +2.0%, with a 90-day well-timed rate of 50.00%. At Colgate-Palmolive specifically, her 4 prior trades demonstrate inconsistent timing: two sales (2024-05-09 and 2024-05-01) returned +8.9% and +9.3% respectively at 90 days, while two earlier sales (2023-05-15 and 2023-05-04) returned -5.7% and -4.5%, yielding a 50% well-timed rate at this ticker. The company trades at a P/E of 29.51 with annual revenue growth of +8.3%, suggesting a mature profile at an elevated valuation multiple. The sale size and timing warrant monitoring to assess whether this represents a pattern shift or routine portfolio activity.
